nano solutions for large biomedical problems
NanoMedTrix is a clinical stage biotechnology company
developing nanoparticles to improve drug target
efficiency
UI Faculty Innovators Program success story
NanoMedTrix awarded $25,000 as part of SBIR/STTR Outreach Program of Bioconnect Iowa
UI nanotechnology firm gets $2 million boost in fight against cancer
NanoMedTrix went from winning pitch competitions to winning multi-million dollar grants, with a little help from JPEC's Faculty Innovators program.
UI nanotechnology firm gets $2 million boost in fight against cancer
NanoMedTrix awarded $25,000 as part of SBIR/STTR Outreach Program of Bioconnect Iowa
UI nanotechnology firm gets $2 million boost in fight against cancer
Eastern Iowa corridor spinoff continues to validate the clinical significance of the novel theranostic.
NanoMedTrix awarded $25,000 as part of SBIR/STTR Outreach Program of Bioconnect Iowa
NanoMedTrix awarded $25,000 as part of SBIR/STTR Outreach Program of Bioconnect Iowa
NanoMedTrix awarded $25,000 as part of SBIR/STTR Outreach Program of Bioconnect Iowa
The funding supplements the NIH Phase II award, in particular commercialization efforts related to establishing a clinical trial network.
Our Nanoparticle Difference
Targeted Platform Technology
With a wide variety of biomedical applications, including delivering precise doses of tumoricidal drugs to target site and used as contrast agents for medical imaging.
Multimodal
A single dose is effective across 2 or more scanning types (PET, MRI , CT, Ultrasound), increasing efficiency and reducing multi scan/multi visit costs
Multiscale
Can work at cellular, tissue and organ level. Capable of targeting particular pathology or tissue type, thereby revolutionizing non invasive disease detection
Reviews
This website uses cookies.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.